◀ Back to EGFR
CTTN — EGFR
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Head et al., Mol Biol Cell 2003
:
Phosphorylation of cortactin tyrosine 421 and 466 was elevated in response to Src,
epidermal growth factor receptor and Rac1
activation , and tyrosine 421 phosphorylated
cortactin localized with F-actin in lamellipodia and podosomes
Timpson et al., Cancer Res 2005
(MAP Kinase Signaling System) :
However, in this study, we show that overexpression of
cortactin in HeLa cells markedly
inhibits ligand induced down-regulation of the
EGFR
van Rossum et al., Breast Cancer Res 2005
(Carcinoma...) :
Cortactin also participates in receptor mediated endocytosis, and recent findings have shown that, during receptor internalization,
cortactin overexpression
inhibits the ubiquitylation mediated degradation of the
epidermal growth factor receptor , resulting in a sustained ligand induced epidermal growth factor receptor activity
Timpson et al., Cancer Res 2007
(Carcinoma, Squamous Cell...) :
Previously, we identified a novel role for cortactin in cancer cells, whereby
cortactin overexpression
attenuated ligand induced down-regulation of the
epidermal growth factor (EGF) receptor ( EGFR ), leading to sustained signaling
Fantozzi et al., Acta Oncol 2008
(Carcinoma, Squamous Cell...) :
It has been suggested that
cortactin overexpression may
increase EGFR levels in these tumors by affecting receptor downregulation, however we recently found by multivariate analysis, that cortactin expression status remained an independent prognostic factor for local recurrence, disease-free survival, and overall survival